发布求助
文献互助 智能选刊 最新文献

Journal watch. AIDS clinical care最新文献

筛选
英文 中文
Abacavir and CVD--more data but no consensus. Studies this year were evenly split, leaving patients and clinicians with few answers. 阿巴卡韦和心血管疾病——更多的数据但没有共识。今年的研究平分秋羹，留给患者和临床医生的答案寥寥无几。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Keith Henry
{"title":"Abacavir and CVD--more data but no consensus. Studies this year were evenly split, leaving patients and clinicians with few answers.","authors":"Keith Henry","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29119300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV vaccine and microbicide trials turn a corner. We still don't have an effective vaccine or microbicide for the clinic, but two major trials this year brought us closer than we've ever been. 艾滋病毒疫苗和杀微生物剂试验出现转机。我们仍然没有有效的疫苗或杀微生物剂用于临床，但今年的两项主要试验使我们比以往任何时候都更接近了。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Salim S Abdool Karim
{"title":"HIV vaccine and microbicide trials turn a corner. We still don't have an effective vaccine or microbicide for the clinic, but two major trials this year brought us closer than we've ever been.","authors":"Salim S Abdool Karim","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29111731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year. Raltegravir，美女与野兽。这种整合酶抑制剂的优点和局限性在今年都很明显。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Helmut Albrecht
{"title":"Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year.","authors":"Helmut Albrecht","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29119299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several "one pill, once-daily" options. HIV药物管道有望提供更多固定剂量组合。到2011年，医疗服务提供者和患者可能能够在几种“一粒，一天一次”的方案中进行选择。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Helmut Albrecht
{"title":"HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several \"one pill, once-daily\" options.","authors":"Helmut Albrecht","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29119301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV treatment as prevention. The jury's still out, but current data seem to support the theory that ART use reduces the likelihood of HIV transmission. 艾滋病毒治疗作为预防。目前尚无定论，但目前的数据似乎支持使用抗逆转录病毒治疗降低艾滋病毒传播可能性的理论。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Carlos del Rosa
{"title":"HIV treatment as prevention. The jury's still out, but current data seem to support the theory that ART use reduces the likelihood of HIV transmission.","authors":"Carlos del Rosa","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"3-4"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29111732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early ART in the setting of acute OIs. Major trials support this approach, but the strategy is not without risk. 急性OIs的早期ART治疗。主要试验支持这种方法，但这种策略并非没有风险。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Paul E Sax
{"title":"Early ART in the setting of acute OIs. Major trials support this approach, but the strategy is not without risk.","authors":"Paul E Sax","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29111734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Definitive results: IL-2 does not benefit HIV-infected patients. Interleukin-2 improves CD4-cell recovery in patients on antiretroviral therapy, but that benefit does not translate into lower risks for disease or death. 最终结果:IL-2对hiv感染患者没有益处。白细胞介素-2可以改善接受抗逆转录病毒治疗的患者的cd4细胞恢复，但这种益处并不能降低患病或死亡的风险。
Journal watch. AIDS clinical care Pub Date : 2010-01-01 DOI: 10.1056/AC201001040000006
Charles B Hicks
{"title":"Definitive results: IL-2 does not benefit HIV-infected patients. Interleukin-2 improves CD4-cell recovery in patients on antiretroviral therapy, but that benefit does not translate into lower risks for disease or death.","authors":"Charles B Hicks","doi":"10.1056/AC201001040000006","DOIUrl":"https://doi.org/10.1056/AC201001040000006","url":null,"abstract":"For years, researchers have tried to find ways to incorporate interleukin (IL)-2 into HIV management, given its positive effects on CD4-cell counts. However, two large trials this year — SILCAAT and ESPRIT — demonstrated that those positive effects do not translate into …","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"3 1","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73460950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Definitive results: IL-2 does not benefit HIV-infected patients. Interleukin-2 improves CD4-cell recovery in patients on antiretroviral therapy, but that benefit does not translate into lower risks for disease or death. 最终结果:IL-2对hiv感染患者没有益处。白细胞介素-2可以改善接受抗逆转录病毒治疗的患者的cd4细胞恢复，但这种益处并不能降低患病或死亡的风险。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Charles B Hicks
{"title":"Definitive results: IL-2 does not benefit HIV-infected patients. Interleukin-2 improves CD4-cell recovery in patients on antiretroviral therapy, but that benefit does not translate into lower risks for disease or death.","authors":"Charles B Hicks","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29111733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
More progress on preventing HIV infection in infants. Three trials this year pointed to the benefits of extending maternal antiretroviral prophylaxis throughout the breast-feeding period. 在预防婴儿感染艾滋病毒方面取得更多进展。今年的三项试验表明，在整个母乳喂养期间延长孕产妇抗逆转录病毒预防治疗是有益的。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Sonia Nagy Chimienti
{"title":"More progress on preventing HIV infection in infants. Three trials this year pointed to the benefits of extending maternal antiretroviral prophylaxis throughout the breast-feeding period.","authors":"Sonia Nagy Chimienti","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"6-7"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29119302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem-cell transplant and the prospect for an HIV cure. A case report points to gene therapy as a potential avenue for controlling HIV without antiretroviral therapy. 干细胞移植和治愈艾滋病的前景。一份病例报告指出，基因治疗是一种无需抗逆转录病毒治疗就能控制艾滋病毒的潜在途径。
Journal watch. AIDS clinical care Pub Date : 2010-01-01
Sonia Nagy Chimienti
{"title":"Stem-cell transplant and the prospect for an HIV cure. A case report points to gene therapy as a potential avenue for controlling HIV without antiretroviral therapy.","authors":"Sonia Nagy Chimienti","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"22 1","pages":"2-3"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29119298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信